New Jersey lawmakers have passed a bill to create a psilocybin therapy pilot program and allocate $6 million in funding to support the effort.
Following its advancement through several House and Senate committees, both full chambers of the legislature approved the psychedelic measure on Monday, sending it to Gov. Phil Murphy (D).
“Studies conducted by nationally and internationally recognized medical institutions indicate that psilocybin has shown efficacy, tolerability, and safety in the treatment of a variety of behavioral health conditions,” the bill’s findings sections says, “including, but not limited to, substance use disorders, depression, anxiety disorders, and end-of-life psychological distress.”
The legislation, sponsored by Senate President Nick Scutari (D) and Sen. Joseph Vitale (D), along with Assemblymembers Clinton Calabrese (D) and Anthony S. Verrelli (D), would create an 11-member Psychedelic Therapy and Research Advisory Board to oversee the new Psilocybin Behavioral Health Services Pilot Program.
“I think it’s a real opportunity for New Jersey to lead an area of medicine that is groundbreaking,” Scutari said, according to NorthJersey.com.
Within 180 days of enactment, the Department of Health would be required to issue a request for proposals from hospitals that want to participate. One hospital from each of three geographic regions
Read full article on Marijuana Moment
